23–26 September 2026 | Rome, Italy Biomedical Bonding AB will be exhibiting at the 7th World Veterinary Orthopaedic Congress (WVOC) in Rome, Italy, where we will showcase our metal-free fracture fixation technologies for veterinary orthopaedics. For over a century, repairing fractured bones has relied primarily on metal implants. Biomedical Bonding is introducing an alternative approach with our light-cured composite fixation technology. Our system enables the surgeon to appl

Independent preclinical results show the light-cured composite is safe and well integrated in living bone, supporting Biomedical Bonding’s approach to replacing the metal fracture plate. Stockholm, Sweden, 18 June 2026. Biomedical Bonding AB (BMB) today announced that an independent, GLP-compliant study has confirmed the safety and biocompatibility of the light-cured composite at the core of its Bonevolent® fracture-fixation platform. The composite was found to be safe and we

Biomedical Bonding AB has entered into a Key Opinion Leader collaboration with Prof. Paul Ackermann, Professor of Orthopaedic Surgery at Karolinska Institutet and Consultant Orthopaedic Surgeon at Karolinska University Hospital, further expanding the clinical network surrounding the Bonevolent® platform. With more than 25 years of clinical and academic experience, Prof. Ackermann's work spans orthopaedic trauma, fracture care, musculoskeletal injury, tissue repair, and transl

Biomedical Bonding AB Advances Bonevolent® AdhFix Toward Veterinary Clinical Use Biomedical Bonding AB has taken another important step toward the veterinary clinical implementation of its Bonevolent® AdhFix technology through an intensive full-day hands-on training session conducted together with veterinary surgeons participating in the company’s upcoming clinical studies. These challenges align closely with the strengths of Bonevolent® AdhFix, an injectable and light-curabl

Patent protects foundational chemistry for light-curable, in situ forming fixation systems Biomedical Bonding AB has been granted U.S. Patent by the United States Patent and Trademark Office (USPTO). The patent covers a composition for fast-curing thermosetting resins based on thiol and unsaturated molecular systems, designed to form rapidly curing crosslinked networks under light activation. This enables controlled material formation and mechanical robustness suitable for

iomedical Bonding AB recently showcased Bonevolent™ to 15 orthopaedic surgeons at the orthopaedic trauma unit at Karolinska University Hospital, marking our first engagement of this scale with the surgical trauma community.

We are thrilled to announce the launch of our newly redesigned webpage interface! The updated design offers a clearer, more intuitive experience, allowing visitors to easily learn about our innovative technology while staying informed on the latest advancements and updates . This refresh reflects our ongoing commitment to accessibility, clarity, and connection; ensuring that every visitor can engage seamlessly with our content and explore the progress driving our work forwa

We are thrilled to announce the launch of our latest pre-clinical implantation study, conducted in collaboration with Research Institutes...

The BoneFix team at the AO Research Institute Davos (ARI) has published another paper in Frontiers in Bioengineering and Biotechnology....